The high expression of LCN2 is significantly correlated with the clinical condition and pathological kidney damage in patients with LN, indicating that LCN2 is involved in the occurrence and development of LN and can be regarded as a potential biomarker. This evidence concerns the gene LCN2 and lobular neoplasia.